tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FDMT Stock Latest News

FDA clears 4D Molecular’s IND Application for 4D-175 for GA treatment
The FlyFDA clears 4D Molecular’s IND Application for 4D-175 for GA treatment
13d ago
FDMT
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
PremiumPress Releases
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
29d ago
FDMT
4D Molecular presents interim data from Phase 1/2 AEROW trial
PremiumThe Fly
4D Molecular presents interim data from Phase 1/2 AEROW trial
1M ago
FDMT
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
PremiumPress Releases
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
1M ago
FDMT
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
PremiumPress Releases
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
1M ago
FDMT
4D Molecular reports Q1 EPS (66c), consensus (74c)
PremiumThe Fly4D Molecular reports Q1 EPS (66c), consensus (74c)
2M ago
FDMT
4D Molecular price target raised to $40 from $35 at RBC Capital
PremiumThe Fly
4D Molecular price target raised to $40 from $35 at RBC Capital
3M ago
FDMT
4D Molecular initiated with an Overweight at Barclays
PremiumThe Fly
4D Molecular initiated with an Overweight at Barclays
3M ago
FDMT
4D Molecular assumed with a Buy at Jefferies
PremiumThe Fly
4D Molecular assumed with a Buy at Jefferies
3M ago
FDMT
4D Molecular price target lowered to $63 from $70 at BMO Capital
PremiumThe Fly
4D Molecular price target lowered to $63 from $70 at BMO Capital
3M ago
FDMT
4D Molecular announce update on regulatory interactions, development for 4D-710
PremiumThe Fly
4D Molecular announce update on regulatory interactions, development for 4D-710
3M ago
FDMT
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
PremiumPress Releases
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
3M ago
FDMT
4DMT to Participate in Upcoming Investor Conferences
PremiumPress Releases4DMT to Participate in Upcoming Investor Conferences
4M ago
FDMT
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
PremiumPress Releases
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
4M ago
FDMT
4D Molecular presents interim data from 4D-310 INGLAXA Phase 1/2 trials
PremiumThe Fly
4D Molecular presents interim data from 4D-310 INGLAXA Phase 1/2 trials
5M ago
FDMT
4D Molecular Therapeutics Secures Major Financial Deal
PremiumCompany Announcements
4D Molecular Therapeutics Secures Major Financial Deal
5M ago
8K
FDMT
4D Molecular price target raised to $82 from $33 at BofA
PremiumThe Fly
4D Molecular price target raised to $82 from $33 at BofA
5M ago
FDMT
Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls
5M ago
ZI
CCK
4D Molecular reinstated with a Buy at Goldman Sachs
PremiumThe Fly
4D Molecular reinstated with a Buy at Goldman Sachs
5M ago
FDMT
4D Molecular 6.59M share Secondary priced at $29.50
PremiumThe Fly4D Molecular 6.59M share Secondary priced at $29.50
5M ago
FDMT
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
PremiumPress Releases
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
5M ago
FDMT
4D Molecular files automatic mixed securities shelf
PremiumThe Fly
4D Molecular files automatic mixed securities shelf
5M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >